Clinical trials are an essential part of advancing new cancer treatments and reducing suffering and death from the disease. However, a significant percentage of cancer clinical trials never get off the ground because not enough patients enroll.
Three years ago, ACS CAN launched the One Degree campaign, calling on Congress to increase federal funding for medical research at the National Institutes of Health (NIH) by $6 billion, including $1 billion for cancer-specific research at the National Cancer Institute (NCI). It was a lofty goal – but an important one to reverse too many years of flat or reduced funding.
ACS CAN and Fight Colorectal Cancer (Fight CRC) teamed up today on Capitol Hill to draw attention to colorectal cancer and the role public policy plays in helping reduce the second-leading cause of cancer death in the U.S. for men and women combined.
Recently in South Dakota, ACS CAN advocated for legislation to enhance patient access to biosimilar drugs, which offer safe and effective treatment options for many diseases including cancer.
Eleven countries signed at trade deal in Chile today that includes language that strengthens tobacco control efforts for the participating countries. Once ratified by the signing countries, tobacco companies won't be able to use the agreement to pursue disputes challenging tobacco control measures adopted by participating countries.